Author:
Fabi Alessandra,Ciccarese Mariangela,Metro Giulio,Savarese Antonella,Giannarelli Diana,Nuzzo Carmen M.,Russillo Michelangelo,Sperduti Isabella,Carbone Ilaria,Bria Emilio,Cognetti Francesco
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Antiemetic Subcommitee of the Multinational Association of Supportive Care in Cancer (1998) Prevention of chemotherapy- and radiotherapy induced emesis: results of the Perugia Consensus Conference. Ann Oncol 9:811–819
2. Demoor C, Cohen L, Eisenberg PD, Grunberg SM, Kim YJ, Rubenstein EB (2003) Oncologists’ compliance with antiemetic guidelines (AEG) and outcomes of patients (pts) receiving emetogenic chemotherapy (CT). Proc Am Soc Clin Oncol 22: Abstract 2924
3. Eisenberg P, Figueroa-Vadillo J, Zamora R, Charu V, Hajdenberg J, Cartmell A, Macciocchi A, Grunberg S, 99-04 Palonosetron Study Group (2003) Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results of a phase III, single-dose trial versus dolasetron. Cancer 98:2473–2482
4. Gandara DR, Roila F, Warr D, Edelman MJ, Perez EA, Gralla RJ (1998) Consensus proposal for 5HT3 antagonists in the prevention of acute emesis related to higly emetogenic chemotherapy. Support Care Cancer 6:237–243
5. Gralla RJ, de Wit R, Herrstedt J, Carides AD, Ianus J, Guoguang-Ma J, Evans JK, Horgan KJ (2005) Antiemetic efficacy of the neurokinin-1 antagonist aprepitant plus a 5HT3 antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to high-dose cisplatin. Cancer 104:864–868
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献